Comparison of Therapeutic Efficacy of Intravitreal Bevacizumab plus Macular Laser versus Intravitreal Triamcinolone Acetonide plus Macular Laser in Primary Treatment of Diabetic Macular Edema
Journal Title: Scholars Journal of Applied Medical Sciences - Year 2017, Vol 5, Issue 8
Abstract
Abstract:To compare the efficacy of intravitreal bevacizumab and macular laser vis-a-vis intravitreal triamcinolone acetonide and macular laser in primary treatment for diabetic macular edema. Randomised, prospective, comparative two-arm, non-interventional study with five time points. 60 eyes of 30 patients with bilateral DME and no previous ocular intervention participated in the study and were randomised into two groups. Both eyes of Group A patients received an intravitreal injection of 1.25mg of Bevacizumab and Group B patients received 4mg of Triamcinolone acetonide. One week after injection, all patients underwent macular photocoagulation. The clinical course of best corrected visual acuity (BCVA) in decimal fraction system and average central retinal thickness (CRT) using optical coherence tomography was monitored for up to 12 weeks after the injection. Before injection, mean of CRT and BCVA were 411.37±165.71µ and 0.252±0.154 in Bevacizumab group (A) and 356.50 ± 152.26µ and 0.378 ±0.248 in Triamcinolone group (B). Two weeks after injection and one week after macular photocoagulation (MPC), both groups showed significant regression of macular edema and improvement in vision. Bevacizumab group showed better results at 2weeks.The difference in CRT and BCVA at 2 weeks from baseline were 84.40 ± 22.68µ (p= .008) & 0.111 ± 0.015 (p< .001) in group A and 52.30± 15.63µ (p= .023) & 0.089± 0.033 (p= .113) in group B. The efficacy of Triamcinolone improved 4th week onwards, became comparable to Bevacizumab group at 8th week. At 12 weeks, the Triamcinolone group achieved slightly better results than Bevacizumab group, which started showing recurrence of macular edema. The differences in CRT at baseline and at 12 weeks in group A and group B respectively are 102.47 ± 23.50 µ(p= .001) and 108 ± 21.60 µ(p< .001).The differences in between baseline and BCVA at 12weeks in group A and group B respectively are 0.210± 0.026 and 0.214±0.04. Within the study period and with the generally used concentration, intravitreal bevacizumab, as treatment modality brings earlier reduction in DME, but at 4 and 8 weeks, the efficacy in terms of p- value in between two groups is similar. At 12 weeks bevacizumab group starts showing the beginning of waning effect of drug, although still comparable to Triamcinolone group. No increase in IOP was seen in bevacizumab group while one eye developed raised IOP in Triamcinolone group. Keywords:Intravitreal injections, Bevacizumab (Avastin), Triamcinolone Acetonide, Macular Laser Photocoagulation, Diabetic Macular Edema
Authors and Affiliations
Kanika Sharma
Keywords
Related Articles
- EP ID EP373173
- DOI -
- Views 58
- Downloads 0
Socio-Demographic Factors Associated with Risk of Cancer Cervix in Women
Carcinoma of cervix is one of the leading malignancies in developing countries including India having an incidence of 14.42 and mortality 2.83 per lakh population .It has a multifactorial etiology. Objectives: To study s...
Prevention of Transmission of HIV from Mother to Child -An Institutional Observational Study
Abstract: Vertical HIV transmission from mother to child accounts for more than 90% of paediatric AIDS. Prevention of mother to child transmission programme (PMTCT) provides, for both enrolment of infected pregnant women...
A Study to Assess the Knowledge on Epilepsy of 1st MBBS Students of Mandya Institute Medical Sciences, Mandya
Epilepsy is the most common neurologic disease. Despite recent advances in the management of epilepsy the efforts to assess knowledge, attitude and practice towards epilepsy are limited, particularly in the developing co...
Frequency of artefacts occurrence in the dead bodies with burn injuries - an analytical study
Abstract: Artefacts from medical intervention are frequently present in medico legal autopsies and must be distinguished from injuries of forensic interest, particularly in death from trauma. The present study was aimed...
Review of Difficult Airway Management
Abstract: The incidence of difficult airway and it's management frequently occur in the operating room. The anesthesiologists possess important responsibility to manage the difficult airway. Airway difficulties may be an...